Mechanisms of pleurodesis (Q27015057)

Ana Montes-Worboys

series ordinal

2

1 reference

language of work or name

1 reference

2012

1 reference

1 reference

83

1 reference

PubMed

issue

2

1 reference

PubMed

page(s)

91-8

1 reference

Management of malignant pleural effusions

PubMed

cites work

1 reference

Pathogenesis of pleural fibrosis

21 January 2018

1 reference

Pleurodesis induced by talc or silver nitrate: evaluation of collagen and elastic fibers in pleural remodeling.

21 January 2018

1 reference

Pathophysiology of the pleura

21 January 2018

1 reference

Pleurodesis: state of the art.

21 January 2018

1 reference

Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis.

21 January 2018

1 reference

Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis

21 January 2018

1 reference

Mechanism of tetracycline-hydrochloride-induced pleurodesis. Tetracycline-hydrochloride-stimulated mesothelial cells produce a growth-factor-like activity for fibroblasts

21 January 2018

1 reference

Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells.

21 January 2018

1 reference

Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.

21 January 2018

1 reference

Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases

21 January 2018

1 reference

Tumor type influences the effectiveness of pleurodesis in malignant effusions

21 January 2018

1 reference

The evidence on the effectiveness of management for malignant pleural effusion: a systematic review

21 January 2018

1 reference

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

21 January 2018

1 reference

Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion

21 January 2018

1 reference

Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions

21 January 2018

1 reference

Is silver nitrate pleurodesis for patients with malignant pleural effusion feasible and safe when performed in an outpatient setting?

21 January 2018

1 reference

Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions

21 January 2018

1 reference

Respiratory muscle strength and lung function in patients undergoing medical thoracoscopy.

21 January 2018

1 reference

Hepatic breast cancer dissemination after an iatrogenic hepatic laceration during talc pleurodesis: a case report.

21 January 2018

1 reference

Respiratory failure following talc pleurodesis

21 January 2018

1 reference

Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value

21 January 2018

1 reference

Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size

21 January 2018

1 reference

Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study

21 January 2018

1 reference

Lung injury following thoracoscopic talc insufflation: experience of a single North American center

21 January 2018

1 reference

Systemic inflammatory reaction after thoracoscopic talc poudrage

21 January 2018

1 reference